Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies

ISSN： 1479-6694

Source： Future Oncology, Vol.8, Iss.3, 2012-03, pp. : 273-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Endocrine Therapies for Breast Cancer

By Howell A. Downey S. Anderson E.

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 576-588

Elsevier

Access to resources Recommend Favorite

Triple-negative breast cancer: molecular characterization and targeted therapies

By Nicholson Allen Bishop Jennifer Lannin Donald Killelea Brigid Guo Xiaojia Cha Charles Dixon J Michael

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 417-430

Future Medicine

Access to resources Recommend Favorite

Development of new predictive markers for endocrine therapy and resistance in breast cancer

By Henriksen Katrine Sonne-Hansen Katrine Kirkegaard Tove Frogne Thomas Lykkesfeldt Anne

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 795-801

Informa Healthcare

Access to resources Recommend Favorite

Resistance to endocrine therapy in breast cancer

By Kurebayashi Junichi

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 39-46

Springer Publishing Company

Access to resources Recommend Favorite

Development of targeted therapies for triple-negative breast cancer: can we harness tumor heterogeneity to improve patient outcomes?

By Diamond Jennifer R Elias Anthony D

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 175-178

Future Medicine

Access to resources Recommend Favorite